Meridian Bioscience Reports Third Quarter And Nine Months Operating Results, Declares Regular Cash Dividend, And Reaffirms Fiscal 2015 Guidance
CINCINNATI--(BUSINESS WIRE)--Meridian Bioscience, Inc. (NASDAQ: VIVO):
GENERAL HIGHLIGHTS
Meridian Bioscience, Inc. (NASDAQ: VIVO) today:
* reported fiscal 2015 third quarter and first nine months net revenues of $48.2 million and $147.8 million, respectively, increases of 2% and 4%, respectively, from the same periods of the prior fiscal year;
* reported third quarter operating income of $14.4 million, an increase of 10% from the same period of the prior fiscal year;
Help employers find you! Check out all the jobs and post your resume.
GENERAL HIGHLIGHTS
Meridian Bioscience, Inc. (NASDAQ: VIVO) today:
* reported fiscal 2015 third quarter and first nine months net revenues of $48.2 million and $147.8 million, respectively, increases of 2% and 4%, respectively, from the same periods of the prior fiscal year;
* reported third quarter operating income of $14.4 million, an increase of 10% from the same period of the prior fiscal year;
Help employers find you! Check out all the jobs and post your resume.